|
NEWS, EVENTS, and DEADLINES
August 5, 2025
| | Introducing the New NJ ACTS K12 Scholars | | NJ ACTS congratulates the latest cohort of scholars chosen for the K12 program. The K12 Scholars Program, DEVELOP, supports the career development of promising junior faculty committed to advancing human health through clinical and translational research. Through a program of research, mentoring, and training, DEVELOP is aimed at training the next generation of scientists to become independent investigators pursuing cutting-edge, impactful health science. | | |
Sarah Fadem, PhD
RBHS Instructor
Rutgers Robert Wood Johnson Medical School
Title of Project: A Data-Driven Approach to Optimizing Cardiovascular Disease Risk Management in Young Breast Cancer Survivors
| | |
Emily Rosenfeld, DO
RBHS Instructor
Rutgers Robert Wood Johnson Medical School
Title of Project: Remote Patient Monitoring for Chronic Hypertension During Pregnancy (REACH)
| | |
Aayush Visaria, MD
RBHS Instructor
Rutgers Robert Wood Johnson Medical School
Title of Project: Improving identification and management of clinical obesity in multiethnic adults with normal BMI
| | |
To learn more about the NJ ACTS K12 Program, please visit our website.
| | Request for Applications - NJ ACTS Element E | | |
NJ ACTS Element E
Funding Opportunity
This RFA solicits innovative projects that address significant roadblocks in clinical and translational science (CTS). Faculty investigators at Rutgers University, Princeton University, New Jersey Institute of Technology, and the RWJBarnabas Health System are eligible to apply.
Projects should:
- Focus on strategies and/or innovations to overcome truly significant challenges in clinical and translational research
- Improve dissemination and/or implementation of evidence-based interventions
- Address a translational research question in a particular disease or intervention context, but provide insights or innovations that are generalizable across different diseases and/or translational research projects
- Increase efficiency and/or effectiveness of research translation
-
Budget up to $162,500 in direct costs per year for up to two years.
| | |
Key Dates:
RFA Release: August 4, 2025
Letter of Intent Deadline: September 15, 2025 (LOI Form Link)
Notification of Projects Selected for Full Proposals: Early October 2025
Full Proposal Deadline: November 21, 2025 by 5:00 PM EST
Award Notification: January 2026
Earliest State Date: May 1, 2026
| | Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | | |
The goal of our fellowship program is to encourage students and Post-Docs to participate in an educational experience where they will explore innovation and commercialization processes while participating in an I-Corps Cohort.
We hope to expand the pipeline of future innovators through this unique program, where Fellows work alongside researchers to help understand customer needs. Selected fellows will receive a fellowship stipend.
Admission is done on a rolling basis.
| | |
Major Autism Study Uncovers Biologically Distinct Subtypes
Researchers at Princeton University and the Simons Foundation have identified four clinically and biologically distinct subtypes of autism, marking a transformative step in understanding the condition’s genetic underpinnings and potential for personalized care. Read the Full Article
Senior study author is Olga Troyanskaya, director of Princeton Precision Health. Dr. Troyanskaya is also a member of the NJ ACTS Academy of Mentors.
| | |
Multicenter Clinical Trial Training Program
The Trial Innovation Network began a program, led by Johns Hopkins, to enhance critical competencies needed for managing multicenter clinical trials effectively.
NJ ACTS congratulates the individuals from Rutgers who applied and were selected to participate in the inaugural cohort of the Multicenter Clinical Trial (MCT) Training Program.
Keri Lunsford, MD, PhD
Anastasia Xynogala
| | CTSA Requests For Information (RFI) | | |
NJ ACTS Engagement with State and Local Government
Respond to RFI by August 29th
NCATS is interested in understanding how CTSAs are engaging with state and local governments in seven domains:
| |
- Leadership and Advisory Roles
- Advocacy & Policy Development
- NOFO for State-Funded Research
| |
- Workforce Development
- Training & Education
- Entrepreneurism & Innovation
- Contract Services
| | |
The NJ ACTS Community Engagement Core (CEC) plays a pivotal role in fostering collaborative academic-community research partnerships and enhancing public knowledge of and trust in clinical and translational research.
One-on-One Consultation
The CEC helps researchers obtain project-specific input from research, community, and patient stakeholders to enhance research design, implementation, and dissemination.
Community Engagement Studios
Our Community Engagement Studios provide a structured approach to engaging members of the community for their meaningful guidance and input on specific research ideas or studies.
To see a salon in action, please click here.
Referrals
The CEC can connect you to experts through our Network of Networks. We help build and sustain long-lasting relationships.
| | Clinical Research Coordination Badge | | |
Do You Want Additional Professional Credentials?
Take Advantage of the NJ ACTS Badge Program
NJ ACTS enthusiastically supports the development of new skills and expertise by developing and offering the research workforce a variety of digital badges. Badges can demonstrate mastery of materials and competence in a set of skills and can help prepare the earner for new career opportunities.
All NJ ACTS Badges are available at: https://njacts.rbhs.rutgers.edu/education-training/badges/
| | |
Clinical Research Coordination (CRC) Level-1
This CRC Badging Course is designed to introduce individuals to the responsibilities, knowledge, and tasks performed by entry-level Clinical Research Coordinators. Participants will achieve level 1 competency in six clinical trial competency domains governing the conduct of clinical trials: Scientific Concepts and Research Design, Ethics & Participant Safety Considerations, Investigational Products Development & Regulation, Clinical Study Operations (GCP), Study and Site Management, and Data Management & Informatics.
The CRC Badging course is self-paced, takes about 20 hours to complete, and consists of 5 modules. Read More
| | NCATS, NIH, and Federal News and Events | |
NCATS Rare Diseases Are Not Rare!
2025 Challenge Prize Competition
The goals of this challenge are to:
(1) Raise awareness for all rare diseases and the people they affect in a collective manner
(2) Highlight the need for cross-cutting research and development of new treatments using multi-disease models
(3) Increase meaningful engagement with the rare disease community
NCATS is seeking innovative ways to communicate with others and educate the public about rare diseases through art disseminated on various platforms by means of changing the way we think about the problem, the way we fund and do research – Ultimately making rare disease drug development more efficient, bringing attention to rare diseases so that they can gain more medical research interest and support, thereby improving lives. Read More
The anticipated Challenge Launch Date is September 2025.
| |
Collaboration Webinars from the
Hear from CTSA TIN experts on trial-related topics to improve your project
| | |
Informed Consent Guidance Manuals and Best Practices & Strategies for Recruiting
September 17
12 - 1 pm
Register
| |  | |
Using Behavior, Economics and Technology to Improve Population Health Outcomes
October 15
12 - 1 pm
Register
| | | |
NJ ACTS Publication Highlights
Bacterial DNA on the skin surface overrepresents the viable skin microbiome. Acosta EM, Little KA, Bratton BP, Lopez JG, Mao X, Payne AS, Donia M, Devenport D, Gitai Z. Elife. 2023 Jun 30;12:RP87192. PMID: 37389570 PMCID: PMC10328497 DOI: 10.7554/eLife.87192
Placental BCRP transporter reduces cadmium accumulation and toxicity in immortalized human trophoblasts. Zhang R, Walker L, Wen X, Doherty C, Gorczyca L, Buckley B, Barrett ES, Aleksunes LM. Reprod Toxicol. 2023 Oct;121:108466. PMID: 37660740 PMCID: PMC10591833 DOI: 10.1016/j.reprotox.2023.108466
| | |
Apply for the Translational Science Interagency Fellowship Program -NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to train fellows in translational science and regulatory science. Learn More about the Program
| |
NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)
| | | | |
